Post by
rbc123 on Aug 21, 2014 4:39pm
Bioniche Life Sciences Announces Overnight Marketed Offering
Bioniche Life Sciences Announces Overnight Marketed Offering BELLEVILLE, ONTARIO--(Marketwired - Aug. 21, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Bioniche Life Sciences Inc. (the "Company") (TSX: BNC), has announced that it has filed a preliminary short form prospectus with the securities regulatory authorities in each of the provinces of Canada, excluding Quebec, in connection with an overnight marketed offering (the "Offering") with Dundee Securities Ltd. acting as the sole agent. The Offering will consist of units of the Company (the "Units"), at a price per Unit and structure to be determined in the context of the market. In connection with the Offering, Bloom Burton & Co. Inc. has been appointed as a selling group member. The Offering is scheduled to close on or about September 10, 2014. The Offering is subject to a number of conditions, including, without limitation, receipt of all regulatory approvals. The net proceeds of the Offering will be used by the Company to complete the filing with the United States Food & Drug Administration (FDA) of a Biologics License Application (BLA) for their lead program Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) for the treatment of patients with high grade non-muscle invasive bladder cancer that have failed Bacillus Calmette-Guerin (BCG) therapy, and for working capital and general corporate purposes. The securities offered have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. About Bioniche Life Sciences Inc. Bioniche Life Sciences Inc. is a clinical stage Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary and innovative therapies for the global human health market. The Company's primary goal is to develop and commercialize products that advance human health and increase shareholder value. For more information, please visit www.Bioniche.com. Except for historical information, this news release may contain "forward-looking statements" and "forward-looking information" within the meaning of applicable securities laws that reflect the Company's current expectation regarding future events, including, without limitation, the proposed use of proceeds and the timing and completion of the Offering. Forward-looking statements and information are necessarily based upon a number of estimates and assumptions that, while, considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Readers are cautioned that any such forward-looking statements and information are not guarantees and there can be no assurance that such statements and information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements and information. These forward-looking statements and information involve risk and uncertainties, which may cause, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process, and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements and information whether as a result of new information, future events or otherwise. All written and oral forward-looking statements and information attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements. FOR FURTHER INFORMATION PLEASE CONTACT: Bioniche Life Sciences Inc. Donald Olds Chief Operating Officer (613) 966-8058 Donald.Olds@Bioniche.com www.Bioniche.com Source: Bioniche Life Sciences Inc. Symbol Symbol Search Market CanadianUS View My Watch Lists Watch List 1 Recent Symbol Last Trade Change % | $ BNC 0.27 Arrow Down -5.26% TWTR 45.11 Arrow Up 0.11% MFC 22.31 Arrow Up 1.73% CIB503 11.00 Arrow Down -0.20% GM 34.60 Arrow Up 0.20% MG 124.18 Arrow Down -0.85% F 17.40 Arrow Down -0.06% CIB513 9.99 Arrow Down -0.21% CIB500 14.14 Arrow Up 0.51% CIB511 10.05 Arrow Down -0.15% Set Alerts Quotes delayed by at least 15 minutes. .
Comment by
IoftheLynchMob on Aug 21, 2014 4:43pm
Interpretation, Your neighbour, who you asked to watch your home while you were on vacation, just sold it for 25 cents on the dollar. He made an effort to market it. He did take out an add in the Pennysaver, without much luck however. Don't worry though, you can trust him to manage the proceeds. It won't happen again! Ha Ha Ha!